Make sure you take part in CBI's 2nd Annual International Stability Programs June 22 - 23, 2000 in Philadelphia, PA
Make sure you take part in CBI's Second Annual International Stability Programs June 22 - 23, 2000 in Philadelphia, PA. This exciting conference gives you the latest updates on FDA and ICH's regulations on stability testing of drug substances, drug products.
You won't want to miss an informative presentation by Jean Blackstone Hill, Regulatory Pharmaceutical Chemist for the FDA. Gain an in-depth look at how to maintain a global stability program and develop strategies on how to achieve harmonization. This is a great chance to take advantage of the networking opportunities this conference offers with high-level decision-makers in the stability industry. Several industry leaders are presenting including: AstraZeneca, Aventis Pharmaceuticals, Baxter Health Care, Cephalon Inc, Glaxo Wellcome, UK, Labware, Lancaster Laboratories, Multisorb, Oread, Pharmacia and Upjohn, Pharm-Eco, PPD Development, and Wyeth Ayerst Research.
Also featured is Pakadee Pothisiri, Ph.D., Ministry of Public Health to talk first hand about the challenges of conducting stability testing in a hot and humid climate. For more information, or to register, contact Kim Hunter at 800 817 8601 or email firstname.lastname@example.org.
The Center for Business Intelligence (CBI), 500 West Cummings Park, Suite 5100, Woburn, MA 01801. Tel: 781-939-2434; Fax: 781-939-2495.